目次

TABLE OF CONTENTS

1 INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 MARKET SCOPE
1.3.1 INCLUSIONS AND EXCLUSIONS
1.3.2 MARKETS COVERED
1.3.3 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 LIMITATIONS
1.6 STAKEHOLDERS
1.7 SUMMARY OF CHANGES
1.8 RECESSION IMPACT

2 RESEARCH METHODOLOGY
2.1 RESEARCH APPROACH
2.2 RESEARCH METHODOLOGY DESIGN
2.2.1 SECONDARY RESEARCH
2.2.1.1 KEY DATA FROM SECONDARY SOURCES
2.2.2 PRIMARY RESEARCH
2.2.2.1 KEY DATA FROM PRIMARY SOURCES
2.2.2.2 INSIGHTS FROM PRIMARY EXPERTS
2.3 MARET SIZE ESTIMATION
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
2.5 MARKET SHARE ESTIMATION
2.6 ASSUMPTIONS FOR THE STUDY
2.7 RISK ASSESSMENT
2.8 IMPACT OF ECONOMIC RECESSION

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.2 RESTRAINTS
5.2.3 OPPORTUNITIES
5.2.4 CHALLENGES
5.3 TECHNOLOGY ANALYSIS
5.3.1 KEY TECHNOLOGY
5.3.2 COMPLIMENTARY TECHNOLOGY
5.3.3 ADJACENT TECHNOLOGY
5.4 INDUSTRY TRENDS
5.5 SUPPLY CHAIN ANALYSIS
5.6 TRADE ANALYSIS
5.7 PORTER'S FIVE FORCE ANALYSIS
5.8 TARIFF AND REGULATORY LANDSCAPE
5.8.1 REGULATORY ANALYSIS
5.8.2 REGULATORY BODIES, GOVERNMENT AGENCIES AND OTHER ORGANIZATION
5.9 PATENT ANALYSIS
5.10 PRICING ANALYSIS
5.10.1 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY WEARABLE INJECTOR
5.10.2 AVERAGE SELLING PRICE TREND, BY REGION
5.11 KEY CONFERENCES & EVENTS DURING 2023-2024
5.12 KEY STAKEHOLDERS & BUYING CRITERIA
5.12.1 KEY STAKEHOLDERS & BUYING PROCESS
5.12.2 BUYING CRITERIA
5.13 ECOSYSTEM/MARKET MAP
5.14 ADJACENT MARKET ANALYSIS
5.15 CASE STUDY ANALYSIS
5.16 REIMBUSREMENT SCENARIO
5.17 VALUE CHAIN ANALYSIS
5.18 TRENDS/DISRUPTION IMPACTING CUSTOMER’S BUSINESS
5.19 UNMET NEEDS/END USER EXPECTATIONS IN WEARABLE INJECTOR

6 WEARABLE INJECTION MARKET, BY TYPE, 2021-2029 (USD MILLION)
6.1 INTRODUCTION
6.2 ON-BODY INJECTOR
6.3 OFF-BODY INJECTOR

7 WEARABLE INJECTION MARKET, BY TECHNOLOGY, 2021-2029 (USD MILLION)
7.1 INTRODUCTION
7.2 SPRING BASED TECHNOLOGY
7.3 MOTOR DRIVEN TECHNOLOGY
7.4 ROTARY PUMP TECHNOLOGY
7.5 EXPANDING BATTERY TECHNOLOGY
7.6 OTHER TECHNOLOGIES

8 WEARABLE INJECTION MARKET, BY INDICATION, 2021-2029 (USD MILLION)
8.1 INTRODUCTION
8.2 DIABETES
8.3 IMMUNO-ONCOLOGY
8.4 CARDIOVASCULAR DISEASE
8.5 CHRONIC PAIN
8.5 OTHER INDICATION

9 WEARABLE INJECTION MARKET, BY END-USER, 2021-2029 (USD MILLION)
9.1 INTRODUCTION
9.2 HOSPITALS AND CLINICS
9.3 HOME CARE SETTINGS
9.4 OTHERS

10 WEARABLE INJECTION MARKET, BY REGION, 2021-2029 (USD MILLION)
10.1 INTRODUCTION
10.2 NORTH AMERICA
10.2.1 IMPACT OF ECONOMIC RECESSION
10.2.2 US
10.2.3 CANADA
10.3 EUROPE
10.3.1 IMPACT OF ECONOMIC RECESSION
10.3.2 GERMANY
10.3.3 FRANCE
10.3.4 UK
10.3.5 ITALY
10.3.6 SPAIN
10.3.7 REST OF EUROPE
10.4 ASIA PACIFIC
10.4.1 IMPACT OF ECONOMIC RECESSION
10.4.2 JAPAN
10.4.3 CHINA
10.4.4 AUSTRALIA
10.4.5 INDIA
10.4.6 SOUTH KOREA
10.4.7 ROAPAC
10.5 LATIN AMERICA
10.5.1 IMPACT OF ECONOMIC RECESSION
10.5.2 BRAZIL
10.5.3 MEXICO
10.5.4 REST OF LATIN AMERICA
10.6 MIDDLE EAST & AFRICA
10.6.1 IMPACT OF ECONOMIC RECESSION
10.7 GCC COUNTRIES
10.7.1 IMPACT OF ECONOMIC RECESSION

11 COMPETITIVE LANDSCAPE
11.1 INTRODUCTION
11.2 KEY PLAYERS STRATEGIES/RIGHT TO WIN
11.3 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS
11.4 COMPANY EVALUATION MATRIX
11.4.1 STARS
11.4.2 EMERGING LEADERS
11.4.3 PERVASIVE PLAYERS
11.4.4 PARTICIPANTS
11.4.5 COMPANY FOOTPRINT
11.5 START-UPS/SME EVALUATION MATRIX
11.5.1 PROGRESSIVE COMPANIES
11.5.2 RESPONSIVE COMPANIES
11.5.3 DYNAMIC COMPANIES
11.5.4 STARTING BLOCKS
11.5.5 COMPETITIVE BENCHMARKING
11.6 BRAND/PRODUCT COMPARATIVE ANALYSIS
11.7 MARKET SHARE ANALYSIS
11.8 COMPETITIVE SITUATION AND TRENDS
11.8.1 PRODUCT LAUNCHES & APPROVALS
11.8.2 DEALS
11.8.3 OTHER DEVELOPMENTS
11.9 R&D ASSESSMENT OF KEY PLAYERS
11.10 INVESTMENT LANDSCAPE

12 COMPANY PROFILE
12.1 KEY PLAYERS
12.1.1 AMGEN INC.
12.1.2 MEDTRONIC PLC
12 1.3 INSULET CORPORATION
12.1.4 YPSOMED
12.1.5 UNITED THERAPEUTICS CORPORATION
12.1.6 SUBCUJECT
12.1.7 ENABLE INJECTIONS
12.1.8 CEQUR SIMPLICITY
12.1.9 GERRESHEIMER
12.1.10 BECTON DICKINSON & COMPANY
12.1.11 WEST PHARMACEUTICAL SERVICES, INC.
12.1.12 ROCHE
12.1.13 TANDEM DIABETES SERVICES, INC.
12.1.14 MANNKIND CORPORATION
12.1.15 SONCEBOZ
12.1.16 NOBLE INTERNATIONAL ALC
12.1.17 ELCAM DRUG DELIVERY DEVICES
12.1.18 JOHNSON AND JOHNSON
12.2 OTHER PLAYERS
12.2.1 STEVANATO GROUP
12.2.2 EOFLOW
12.2.3 WEIIBEL CDS
12.2.4 VALERITAS
12.2.5 LTS LOHMANN THERAPIE-SYSTEME AG
12.2.6 KYMANOX CORPORATION
12.2.7 INCUBEX

13 APPENDIX
13.1 INSIGHTS OF INDUSTRY EXPERTS
13.2 DISCUSSION GUIDE
13.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.4 RELATED REPORTS
13.5 AUTHOR DETAILS